The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro) by 2024.

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs. First ...

Typically, the hormone insulin helps move glucose from your blood to your cells, where it’s used for energy. But with type 2 diabetes, your body’s cells aren’t able to respond to insulin as ...

Humulin N isn’t a type of regular insulin. Regular insulins are typically short-acting insulins, which take about 30 minutes to start working after they’re injected.

If you're looking to take your gameplay to the next level, one of the best PS5 controllers is what you need. But which one is right for you?

The symptoms of high blood sugar include frequent urination, fatigue, blurry vision, frequent hunger, and tingling in your limbs. Here’s what to do to manage your diabetes.